Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients
Article
[키워드] acting
acute respiratory syndrome
added
Administered
administration
Amplicon sequencing
analyses
Analysis
antibody
Antiviral
antiviral property
antiviral strategy
applied
Bacteria
benefit
Care
chills
collected
Combined
coronavirus
coronavirus disease
COVID-19
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
detectable
Diagnosis
diarrhea
double-blind
dried blood spot
eligible
evaluated
Fever
Health
hospital
Hospitalization
infected with SARS-CoV-2
Lactobacillaceae
lactobacilli
Microbiome
modulation
multifactorial
nasopharyngeal viral load
nose-throat swab
online questionnaire
Outpatient
Pain
Patient
per-protocol analysis
Placebo
placebo-controlled trial
positive
potential mechanism
practitioners
qPCR
quantitative PCR
Randomized
reduce
reducing
reported
reported symptom
respiratory tract infection
respiratory viral disease
SARS-CoV-2
selected
sequence
severity
significantly
spray
strain
Symptom
symptom resolution
the patient
the placebo group
therapy
Throat
throat spray.
Treatment
Trial
trials
upper respiratory tract
Vaccines
variant
Viral diseases
viral infection
Viral load
was performed
[DOI] 10.1128/spectrum.01682-22 PMC 바로가기
[DOI] 10.1128/spectrum.01682-22 PMC 바로가기